Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
H5N1 Influenza Vaccine in Japanese Elderly
NCT01774032Phase 3Completed
- Sponsor
- Resilience Government Services
- Start
- Mar 2013
- Primary completion
- Jun 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of inactivated Vero cell based whole virus influenza A/H5N1, sponsored by Resilience Government Services. Started Mar 2013; status: completed.
02
Drugs
inactivated Vero cell based whole virus influenza A/H5N1
Beyond the preview
Go deeper on NCT01774032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01774032.